In MS, the altered Foxp3-E2 variant-associated inhibitory activity of Treg cells is associated with defective signaling via IL-2 and glycolysis, which modulates Treg cell induction and function in autoimmunity [72]. This evidence concerns the gene IL2 and myeloid sarcoma.